RIKEN researchers have discovered how an enzyme modifies gene expression by targeting certain stretches of messenger RNA ...
Discover how circular RNA technology enhances gene expression by up to 50-fold in eye treatments, surpassing traditional ...
Tezepelumab is associated with beneficial changes in nasal polyp gene expression in patients with chronic rhinosinusitis with ...
Emerging modalities such as self-amplifying and circular RNA, expanding oncology and rare-disease applications, and scalable manufacturing are creating high-growth investment avenues, supported by ...
A mysterious RNA found in breast cancer led scientists to uncover an entire hidden class of cancer-specific RNAs across ...
News-Medical.Net on MSN
New review explains how circular RNAs could unlock fat browning therapies
By Pooja Toshniwal Paharia Preclinical studies increasingly place circular RNAs at the intersection of thermogenic programming and organelle stress control, raising the possibility that these stable ...
Published as an arXiv preprint, the paper details how unsupervised and self-supervised AI models are matching or surpassing supervised systems while uncovering biological patterns that traditional ...
Ultrasound-mediated nanobubbles improve cancer therapy by softening tumors, enhancing lipid nanoparticle distribution, and ...
Researchers found that nonsense-mediated mRNA decay, via the UPF2 protein, is crucial for neuronal migration and cortical ...
Pharmaceutical Technology on MSN
RNA-targeting small molecules: a new frontier of drug discovery
With big pharma signalling interest in novel RNA-targeted approaches, the term “druggable” is being redefined as technology advances.
Researchers discover that the RNA surveillance system NMD and the protein UPF2 are essential for guiding neuronal migration and forming the brain's layered cortex.
The collaborations will provide Illumina's customers with workflows for genomic disease characterization and spatial mapping.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results